Infectious Disease Diagnostics Market Size and Forecasts (2020 – 2030)

Infectious Disease Diagnostics Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology  (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Send Enquiry
Item ID: TIPHE100001430 Category: Tags: , ,

$3,185$5,985

Description

The infectious disease diagnostics market is expected to grow from US$ 38.366 billion in 2022 to US$ 59.954 billion by 2030; it is anticipated to register a CAGR of 5.7% from 2022 to 2030. The growing incidence of infectious diseases across the world and rising application of diagnostics in veterinary infectious diseases bolster the infectious disease diagnostics market size. However, an inadequate reimbursement scenario hinders the infectious disease diagnostics market growth.

Rising Incidence of Infectious Diseases Drive Infectious Disease Diagnostics Market Growth

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0–14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.

According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total cases of TB, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

The report segments the infectious disease diagnostics market as follows:

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Product-Based Insights

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022–2030.

Regional-Based Insights

Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022–2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players.

Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.

A few of the major primary and secondary sources referred to while preparing the report on the infectious disease diagnostics market are the World Health Organization (WHO), the US Census Bureau, The Journal for Infectious Diseases, International Journal of Infectious Diseases, and CDC, among others.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Rising Incidence of Infectious Diseases is expected Drive the Overall Infectious Disease Diagnostics Market Growth

According to our new research study on “Infectious Disease Diagnostics Market Forecast to 2030 – Global Analysis – by Product, Technology, Application Type, Testing Type, End User, and Geography” the infectious disease diagnostics market is expected to grow from US$ 38.366 billion in 2022 to US$ 59.954 billion by 2030; it is anticipated to record a CAGR of 5.7% from 2022 to 2030. The report emphasizes the trends prevalent in the global infectious disease diagnostics market, along with drivers and deterrents impacting its growth.

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0–14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.

According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total cases of TB, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

Rising Application of Diagnostics in Veterinary Infectious Disease

Veterinary infectious diseases negatively impact the health of domestic animals, livestock, and wildlife. As a result of intensive animal farming, there are conditions for the emergence and amplification of disease epidemics due to the genetic and physical proximity of the billions of animals, often in frail health, that are raised indoors every year. Moreover, animal farming contributes to the spread of infections from wild animals due to deforestation caused by the expansion of agricultural land use.

Diagnostic technologies that can detect emerging infectious animal diseases at an early stage are essential to reduce economic losses associated with outbreaks of such diseases. Polymerase chain reaction (PCR) remains the most widely used molecular assay globally to detect animal pathogens. Diagnostic methods of this type are easy to use, cost-effective, susceptible, and specific, with the ability to detect at a high volume.

Even though conventional virological methods are incredibly reliable, they are time-consuming and labor-intensive procedures. Lateral flow and enzyme-linked immunosorbent assay can be used for rapid detection. Multiplex bead immuno or Luminex assay is a fluorescent beads-based high-throughput quantitative technique used for the detection of multiple antibodies specific for different infectious diseases at the same time in a single reaction, leading to more rapid, economical, and accurate results compared with conventional ELISA. In addition, the protein chip based on surface plasmon resonance (SPR) appears to be a rapid valuable tool in the sero-diagnosis of infection or antibody titration. Recombinant antibodies can also be produced in heterologous systems by using rDNA technology and used for developing diagnostic tests.

Point-of-care diagnostics (POCDs) are simple, rapid, and portable diagnostic devices that can detect the disease status at the field level. In recent years, real-time PCR (qPCR) has been transitioned into a POCD platform. These fully automated platforms combine nucleic acid extraction, thermal cycling, and on-site reporting results. For instance, MiniLab from Enigma Diagnostics is a molecular diagnostic platform of 10–35 kg that is carried at the field level and used for validating African swine fever virus, classical swine fever virus, avian influenza virus, and foot-and-mouth disease virus for research purposes. The genesig detection kits of Primerdesign Ltd, UK supply lyophilized qPCR assay kits for the diagnosis of 62 bovine, 42 equine, 47 porcine, 60 avian, 40 canine, and 26 feline pathogens for research purposes. Similarly, Boster offers Bosterbio qPCR kits to detect up to 48 individual or pooled samples. It is used for gene expression profiling, target DNA quantification, microbial detection, viral or bacterial pathogen load determination, and evaluation of primer pair performance for probe-based qPCR.

Thus, diagnostics methods such as PCR and qPCR to diagnose bacterial, viral, fungal, and parasitic infections in animals is fueling the diagnostics in veterinary diagnosis.

Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.

Infectious Disease Diagnostics Market, by Region, 2022 (%)

Source:the research team Analysis

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis Formulation:
3.2.4 Macro-economic Factor Analysis:
3.2.5 Developing Base Number:
3.2.6 Data Triangulation:
3.2.7 Country Level Data:
4. Asia Pacific Frozen Waffles Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 The threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Value Chain Analysis
4.4.1 Raw Material
4.4.2 Manufacturing/Processing
4.4.3 Packaging
5. Asia Pacific Frozen Waffles Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Demand for Frozen and Convenience Food Worldwide
5.1.2 Rising Trend of In-Home Consumption
5.2 Market Restraints
5.2.1 High Preference for Traditional Breakfast Products in Selected Countries
5.3 Market Opportunities
5.3.1 Product Innovation
5.4 Future Trends
5.4.1 Rising Growth of E-commerce
5.5 Impact Analysis of Drivers and Restraints
6. Frozen Waffles -Asia Pacific Market Analysis
6.1 Asia Pacific Frozen Waffles Market Overview
6.2 Asia Pacific Frozen Waffles Market -Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Frozen Waffles Market Analysis – By Type
7.1 Overview
7.2 Asia Pacific Frozen Waffles Market, By Type (2022 and 2030)
7.3 Flavored
7.3.1 Overview
7.3.2 Flavored: Asia Pacific Frozen Waffles Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Unflavored/Plain
7.4.1 Overview
7.4.2 Unflavored/Plain: Asia Pacific Frozen Waffles Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Frozen Waffles Market Analysis – By Category
8.1 Overview
8.2 Asia Pacific Frozen Waffles Market, By Category (2022 and 2030)
8.3 Gluten-free
8.3.1 Overview
8.3.2 Gluten-free: Asia Pacific Frozen Waffles Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Conventional
8.4.1 Overview
8.4.2 Conventional: Asia Pacific Frozen Waffles Market – Revenue and Forecast to 2030 (US$ Million)
9. Frozen Waffles Market Analysis – By Distribution Channel
9.1 Overview
9.2 Asia Pacific Frozen Waffles Market, By Distribution Channel (2022 and 2030)
9.3 Supermarkets and Hypermarkets
9.3.1 Overview
9.3.2 Supermarkets and Hypermarkets: Asia Pacific Frozen Waffles Market- Revenue and Forecast to 2030 (US$ Million)
9.4 Convenience Stores
9.4.1 Overview
9.4.2 Convenience Stores: Asia Pacific Frozen Waffles Market- Revenue and Forecast to 2030 (US$ Million)
9.5 Online Retail
9.5.1 Overview
9.5.2 Online Retail: Asia Pacific Frozen Waffles Market- Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Asia Pacific Frozen Waffles Market- Revenue and Forecast to 2030 (US$ Million)
10. Frozen Waffles Market – Country Analysis
10.1 Overview: Asia Pacific Frozen Waffles Market
10.1.1 Asia Pacific Frozen Waffles Market, by Key Countries – Revenue (2022) (US$ Million)
10.1.3 Asia Pacific Frozen Waffles Market Breakdown by Key Countries
10.1.3.1 Australia Frozen Waffles Market Revenue Forecasts to 2030 (US$ Million)
10.1.3.1.1 Australia Frozen Waffles Market Breakdown by Type
10.1.3.1.2 Australia Frozen Waffles Market Breakdown by Category
10.1.3.1.3 Australia Frozen Waffles Market Breakdown by Distribution Channel
10.1.3.2 China Frozen Waffles Market Revenue Forecasts to 2030 (US$ Million)
10.1.3.2.1 China Frozen Waffles Market Breakdown by Type
10.1.3.2.2 China Frozen Waffles Market Breakdown by Category
10.1.3.2.3 China Frozen Waffles Market Breakdown by Distribution Channel
10.1.3.3 India Frozen Waffles Market Revenue Forecasts to 2030 (US$ Million)
10.1.3.3.1 India Frozen Waffles Market Breakdown by Type
10.1.3.3.2 India Frozen Waffles Market Breakdown by Category
10.1.3.3.3 India Frozen Waffles Market Breakdown by Distribution Channel
10.1.3.4 Japan Frozen Waffles Market Revenue Forecasts to 2030 (US$ Million)
10.1.3.4.1 Japan Frozen Waffles Market Breakdown by Type
10.1.3.4.2 Japan Frozen Waffles Market Breakdown by Category
10.1.3.4.3 Japan Frozen Waffles Market Breakdown by Distribution Channel
10.1.3.5 South Korea Frozen Waffles Market Revenue Forecasts to 2030 (US$ Million)
10.1.3.5.1 South Korea Frozen Waffles Market Breakdown by Type
10.1.3.5.2 South Korea Frozen Waffles Market Breakdown by Category
10.1.3.5.3 South Korea Frozen Waffles Market Breakdown by Distribution Channel
10.1.3.6 Rest of Asia Pacific Frozen Waffles Market Revenue Forecasts to 2030 (US$ Million)
10.1.3.6.1 Rest of Asia Pacific Frozen Waffles Market Breakdown by Type
10.1.3.6.2 Rest of Asia Pacific Frozen Waffles Market Breakdown by Category
10.1.3.6.3 Rest of Asia Pacific Frozen Waffles Market Breakdown by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 New Product Development
12. Company Profiles
12.1 DELY Wafels SRL
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Avieta SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Kellogg Co
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Planetary Foods Pvt Ltd (Waffle Mill)
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. Appendix
13.1 About
13.2 Word Index

LIST OF TABLES

Table 1. Infectious Disease Diagnostics Market Segmentation. 40
Table 2. Infectious Diseases and Fundings. 51
Table 3. Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 63
Table 4. Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 64
Table 5. Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 73
Table 6. North America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 83
Table 7. North America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 84
Table 8. North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 84
Table 9. North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 85
Table 10. North America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 85
Table 11. North America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 86
Table 12. North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 86
Table 13. North America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 87
Table 14. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 88
Table 15. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 90
Table 16. US Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 90
Table 17. US Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 91
Table 18. US Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 19. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 20. US Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 21. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 93
Table 22. Canada Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 95
Table 23. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 96
Table 24. Canada Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 96
Table 25. Canada Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 97
Table 26. Canada Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 97
Table 27. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 98
Table 28. Canada Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 98
Table 29. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 99
Table 30. Mexico Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 101
Table 31. Mexico Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 102
Table 32. Mexico Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 102
Table 33. Mexico Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 103
Table 34. Mexico Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 103
Table 35. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 103
Table 36. Mexico Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 104
Table 37. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 104
Table 38. Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 106
Table 39. Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 107
Table 40. Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 107
Table 41. Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 108
Table 42. Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 108
Table 43. Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 109
Table 44. Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 109
Table 45. Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 110
Table 46. UK Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 111
Table 47. UK Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 113
Table 48. UK Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 113
Table 49. UK Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 114
Table 50. UK Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 114
Table 51. UK Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 115
Table 52. UK Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 115
Table 53. UK Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 116
Table 54. Germany Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 118
Table 55. Germany Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 119
Table 56. Germany Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 119
Table 57. Germany Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 120
Table 58. Germany Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 120
Table 59. Germany Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 121
Table 60. Germany Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 121
Table 61. Germany Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 122
Table 62. France Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 123
Table 63. France Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 125
Table 64. France Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 125
Table 65. France Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 126
Table 66. France Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 126
Table 67. France Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 127
Table 68. France Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 127
Table 69. France Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 128
Table 70. Italy Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 129
Table 71. Italy Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 131
Table 72. Italy Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 131
Table 73. Italy Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 132
Table 74. Italy Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 132
Table 75. Italy Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 132
Table 76. Italy Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 133
Table 77. Italy Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 133
Table 78. Spain Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 134
Table 79. Spain Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 136
Table 80. Spain Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 136
Table 81. Spain Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 137
Table 82. Spain Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 137
Table 83. Spain Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 137
Table 84. Spain Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 138
Table 85. Spain Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 138
Table 86. Rest of Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 140
Table 87. Rest of Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 141
Table 88. Rest of Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 141
Table 89. Rest of Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 142
Table 90. Rest of Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 142
Table 91. Rest of Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 143
Table 92. Rest of Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 143
Table 93. Rest of Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 144
Table 94. Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 146
Table 95. Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 147
Table 96. Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 147
Table 97. Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 148
Table 98. Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 148
Table 99. Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 149
Table 100. Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 149
Table 101. Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 150
Table 102. China Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 153
Table 103. China Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 153
Table 104. China Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 154
Table 105. China Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 154
Table 106. China Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 155
Table 107. China Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 155
Table 108. China Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 156
Table 109. China Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 156
Table 110. Japan Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 157
Table 111. Japan Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 159
Table 112. Japan Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 159
Table 113. Japan Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 160
Table 114. Japan Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 160
Table 115. Japan Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 160
Table 116. Japan Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 161
Table 117. Japan Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 161
Table 118. India Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 162
Table 119. India Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 164
Table 120. India Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 164
Table 121. India Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 165
Table 122. India Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 165
Table 123. India Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 165
Table 124. India Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 166
Table 125. India Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 166
Table 126. South Korea Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 167
Table 127. South Korea Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 169
Table 128. South Korea Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 169
Table 129. South Korea Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 170
Table 130. South Korea Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 170
Table 131. South Korea Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 170
Table 132. South Korea Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 171
Table 133. South Korea Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 171
Table 134. Australia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 172
Table 135. Australia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 174
Table 136. Australia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 174
Table 137. Australia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 175
Table 138. Australia Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 175
Table 139. Australia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 175
Table 140. Australia Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 176
Table 141. Australia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 176
Table 142. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 177
Table 143. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 179
Table 144. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 179
Table 145. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 180
Table 146. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 180
Table 147. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 181
Table 148. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 181
Table 149. Rest of Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 182
Table 150. Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 184
Table 151. Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 185
Table 152. Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 185
Table 153. Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 186
Table 154. Middle East & Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 186
Table 155. Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 187
Table 156. Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 187
Table 157. Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 188
Table 158. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 189
Table 159. Saudi Arabia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 191
Table 160. Saudi Arabia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 191
Table 161. Saudi Arabia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 192
Table 162. Saudi Arabia Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 192
Table 163. Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 192
Table 164. Saudi Arabia Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 193
Table 165. Saudi Arabia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 193
Table 166. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 194
Table 167. South Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 196
Table 168. South Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 196
Table 169. South Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 197
Table 170. South Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 197
Table 171. South Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 197
Table 172. South Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 198
Table 173. South Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 198
Table 174. UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 199
Table 175. UAE Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 201
Table 176. UAE Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 201
Table 177. UAE Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 202
Table 178. UAE Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 202
Table 179. UAE Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 202
Table 180. UAE Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 203
Table 181. UAE Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 203
Table 182. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 204
Table 183. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 206
Table 184. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 206
Table 185. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 207
Table 186. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 207
Table 187. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 208
Table 188. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 208
Table 189. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 209
Table 190. South & Central America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 211
Table 191. South & Central America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 212
Table 192. South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 212
Table 193. South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 213
Table 194. South & Central America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 213
Table 195. South & Central America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 214
Table 196. South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 214
Table 197. South & Central America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 215
Table 198. Brazil Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 216
Table 199. Brazil Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 218
Table 200. Brazil Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 218
Table 201. Brazil Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 219
Table 202. Brazil Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 219
Table 203. Brazil Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 219
Table 204. Brazil Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 220
Table 205. Brazil Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 220
Table 206. Argentina Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 221
Table 207. Argentina Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 223
Table 208. Argentina Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 223
Table 209. Argentina Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 224
Table 210. Argentina Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 224
Table 211. Argentina Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 224
Table 212. Argentina Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 225
Table 213. Argentina Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 225
Table 214. Rest of South & Central America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 226
Table 215. Rest of South & Central America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 227
Table 216. Rest of South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 227
Table 217. Rest of South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 228
Table 218. Rest of South & Central America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 228
Table 219. Rest of South & Central America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 229
Table 220. Rest of South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 229
Table 221. Rest of South & Central America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 230
Table 222. Organic Developments Done By Companies. 232
Table 223. Inorganic Developments Done By Companies. 234
Table 224. Glossary of Terms, Infectious Disease Diagnostics Market 278

LIST OF FIGURES

Figure 1. Infectious Disease Diagnostics Market Segmentation, By Geography. 41
Figure 2. Global – PEST Analysis. 47
Figure 3. Infectious Disease Diagnostics Market – Key Industry Dynamics. 48
Figure 4. Impact Analysis of Drivers and Restraints. 53
Figure 5. Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030. 54
Figure 6. Infectious Disease Diagnostics Market Revenue, Geography (US$ Mn), 2022 – 2030. 55
Figure 7. Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
Figure 8. Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 57
Figure 9. Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 58
Figure 10. Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 59
Figure 11. Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
Figure 12. Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 61
Figure 13. Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 62
Figure 14. Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 64
Figure 15. Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 66
Figure 16. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 67
Figure 17. Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
Figure 18. Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 69
Figure 19. Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 70
Figure 20. Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
Figure 21. Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 72
Figure 22. Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 74
Figure 23. Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
Figure 24. Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 76
Figure 25. Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 77
Figure 26. Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 78
Figure 27. Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 80
Figure 28. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 81
Figure 29. North America: Infectious Disease Diagnostics Market, by Key Country – Revenue (2022) (US$ Million) 82
Figure 30. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
Figure 31. North America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 87
Figure 32. US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
Figure 33. Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
Figure 34. Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
Figure 35. Europe Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 105
Figure 36. Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
Figure 37. Europe Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 110
Figure 38. UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
Figure 39. Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
Figure 40. France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
Figure 41. Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
Figure 42. Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
Figure 43. Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
Figure 44. Asia Pacific Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 145
Figure 45. Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
Figure 46. Asia Pacific Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 151
Figure 47. China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
Figure 48. Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
Figure 49. India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
Figure 50. South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
Figure 51. Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
Figure 52. Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
Figure 53. Middle East & Africa Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 183
Figure 54. Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
Figure 55. Middle East & Africa Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 188
Figure 56. Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
Figure 57. South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
Figure 58. UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
Figure 59. Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
Figure 60. South & Central America Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 210
Figure 61. South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
Figure 62. South & Central America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 215
Figure 63. Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
Figure 64. Argentina Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 221
Figure 65. Rest of South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 226
Figure 66. Growth Strategies Done by the Companies in the Market, (%) 231

The List of Companies – Infectious Disease Diagnostics Market 
– Abbott Laboratories
– Bruker Corp
– Cardinal Health
– F. Hoffmann-La Roche Ltd
– Trinity Biotech Plc
– Danaher Corp
– Bio-Rad Laboratories Inc
– AccuBioTech Co Ltd
– ACON Laboratories
– DiaSorin SpA

Reviews

There are no reviews yet.

Be the first to review “Infectious Disease Diagnostics Market Size and Forecasts (2020 – 2030)”